GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Baskhanbiopharma Inc (XKRX:354390) » Definitions » Loans Receivable

Switch to:

Baskhanbiopharma (XKRX:354390) Loans Receivable : ₩0 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Baskhanbiopharma Loans Receivable?

Baskhanbiopharma's Loans Receivable for the quarter that ended in Dec. 2024 was ₩0 Mil.

Baskhanbiopharma Loans Receivable Historical Data

The historical data trend for Baskhanbiopharma's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baskhanbiopharma Loans Receivable Chart

Baskhanbiopharma Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Loans Receivable

-

-

-

-

-

Baskhanbiopharma Semi-Annual Data
	Dec20	Dec21	Dec22	Dec23	Dec24
Loans Receivable	-	-	-	-	-

Baskhanbiopharma Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Baskhanbiopharma Loans Receivable Related Terms

Thank you for viewing the detailed overview of Baskhanbiopharma's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Baskhanbiopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Baskhanbiopharma Inc (XKRX:354390) » Definitions » Loans Receivable

Traded in Other Exchanges

N/A

Address

354 Wondang-ro, Wongok-myeon, Anseong-si, Gyeonggi-do, KOR

Website

https://www.baskhanbio.com

Baskhanbiopharma Inc manufactures and distributes prescription drugs, over the counter drugs, medical devices and other related products.

Baskhanbiopharma Headlines

No Headlines

Home About Jobs Site Map Term of Use Privacy Policy Mobile App Referral Program Partner Program FAQ Contact Us 中文 All-In-One Screener
Stock List Guru List Insider List Insider Trade Economic Indicators Industry Data DCF Calculator Discussion Board Plans Excel Add-In Google Sheets Add-on
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.